$1.60
0.053.23%
At close: -
$1.55
-0.05-3.13%
After Hours: May 2, 5:26 PM EDT
Comments
Loading...
TScan Therapeutics (TCRX) Forecast
NewsEarningsTScan Therapeutics (TCRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
TScan Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TCRX | Benzinga
Explore TScan Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TCRX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy TScan Therapeutics (TCRX) stock?
You can purchase shares of TScan Therapeutics (NASDAQ:TCRX) through any online brokerage.
Who are TScan Therapeutics (TCRX) competitors?
Other companies in TScan Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), OncoCyte (NASDAQ:OCX), Inozyme Pharma (NASDAQ:INZY) and Elicio Therapeutics (NASDAQ:ELTX).
What is the forecast, or price target, for TScan Therapeutics (TCRX) stock?
TScan Therapeutics has a consensus price target of $9.83.
What is the current price for TScan Therapeutics (TCRX)?
The stock price for TScan Therapeutics (NASDAQ: TCRX) is $1.55 last updated May 2, 2025 at 5:26 PM EDT.
Does TScan Therapeutics (TCRX) pay a dividend?
A quarterly cash dividend of 0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.
When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?
TScan Therapeutics’s Q1 earnings are confirmed for Friday, May 16, 2025.
Is TScan Therapeutics (TCRX) going to split?
There is no upcoming split for TScan Therapeutics.
What sector and industry does TScan Therapeutics (TCRX) operate in?
TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
